Avior Wealth Management’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $347K | Sell |
8,128
-1,177
| -13% | -$63.9K | 0.01% | 612 |
|
|
2026
Q1 | $584K | Buy |
9,305
+391
| +4% | +$31.3K | 0.02% | 491 |
|
|
2025
Q4 | $850K | Sell |
8,914
-11
| -0.1% | -$1.08K | 0.03% | 336 |
|
|
2025
Q3 | $871K | Buy |
8,925
+43
| +0.5% | +$4.45K | 0.03% | 327 |
|
|
2025
Q2 | $954K | Buy |
8,882
+3,035
| +52% | +$307K | 0.03% | 290 |
|
|
2025
Q1 | $590K | Sell |
5,847
-3,312
| -36% | -$334K | 0.02% | 363 |
|
|
2024
Q4 | $818K | Sell |
9,159
-2,473
| -21% | -$218K | 0.03% | 324 |
|
|
2024
Q3 | $975K | Buy |
11,632
+436
| +4% | +$34.4K | 0.04% | 294 |
|
|
2024
Q2 | $862K | Sell |
11,196
-2,496
| -18% | -$183K | 0.04% | 305 |
|
|
2024
Q1 | $938K | Buy |
13,692
+1,468
| +12% | +$94.4K | 0.04% | 301 |
|
|
2023
Q4 | $707K | Sell |
12,224
-1,213
| -9% | -$64.7K | 0.04% | 266 |
|
|
2023
Q3 | $709K | Hold |
13,437
| – | – | 0.05% | 252 |
|
|
2023
Q2 | $727K | Sell |
13,437
-1,810
| -12% | -$94.5K | 0.05% | 258 |
|
|
2023
Q1 | $763K | Buy |
15,247
+25
| +0.2% | +$1.18K | 0.05% | 242 |
|
|
2022
Q4 | $704K | Sell |
15,222
-345
| -2% | -$14.9K | 0.05% | 235 |
|
|
2022
Q3 | $602K | Hold |
15,567
| – | – | 0.05% | 237 |
|
|
2022
Q2 | $579K | Hold |
15,567
| – | – | 0.06% | 231 |
|
|
2022
Q1 | $689K | Buy |
15,567
+1,677
| +12% | +$72.7K | 0.06% | 227 |
|
|
2021
Q4 | $589K | Sell |
13,890
-5,053
| -27% | -$212K | 0.05% | 293 |
|
|
2021
Q3 | $821K | Buy |
18,943
+11,017
| +139% | +$487K | 0.07% | 220 |
|
|
2021
Q2 | $338K | Hold |
7,926
| – | – | 0.03% | 350 |
|
|
2021
Q1 | $306K | Sell |
7,926
-1
| -0% | -$38 | 0.03% | 357 |
|
|
2020
Q4 | $284K | Buy |
7,927
+1,591
| +25% | +$57.3K | 0.04% | 350 |
|
|
2020
Q3 | $241K | Sell |
6,336
-1,807
| -22% | -$69.6K | 0.03% | 356 |
|
|
2020
Q2 | $285K | Buy |
8,143
+7,262
| +824% | +$262K | 0.04% | 335 |
|
|
2020
Q1 | $28K | Buy |
881
+50
| +6% | +$1.95K | 0.01% | 489 |
|
|
2019
Q4 | $37K | Hold |
831
| – | – | 0.01% | 486 |
|
|
2019
Q3 | $33K | Buy |
831
+31
| +4% | +$1.31K | 0.01% | 488 |
|
|
2019
Q2 | $34K | Hold |
800
| – | – | 0.01% | 482 |
|
|
2019
Q1 | $30K | Buy |
800
+300
| +60% | +$11.5K | 0.01% | 462 |
|
|
2018
Q4 | $17K | Hold |
500
| – | – | ﹤0.01% | 536 |
|
|
2018
Q3 | $19K | Hold |
500
| – | – | ﹤0.01% | 542 |
|
|
2018
Q2 | $16K | Sell |
500
-13
| -3% | -$392 | ﹤0.01% | 557 |
|
|
2018
Q1 | $14K | Hold |
513
| – | – | ﹤0.01% | 562 |
|
|
2017
Q4 | $13K | Buy |
513
+13
| +3% | +$359 | ﹤0.01% | 575 |
|
|
2017
Q3 | $15K | Hold |
500
| – | – | ﹤0.01% | 298 |
|
|
2017
Q2 | $14K | Hold |
500
| – | – | 0.01% | 284 |
|
|
2017
Q1 | $12K | Buy |
+500
| New | +$12.2K | ﹤0.01% | 333 |
|
Other funds holding BSX
Avior Wealth Management's BSX Position: Q2 2026 in Review
Avior Wealth Management reduced its Boston Scientific (BSX) stake by 13% in Q2 2026, selling an estimated $63.9K and leaving 8,128 shares worth $347K. The position accounts for 0.01% of the portfolio, ranked #612.
Avior Wealth Management first reported a position in BSX in Q1 2017 and has held it in 38 quarters since. The position peaked at $975K in Q3 2024. 1,470 funds tracked by Wall St. Rank hold BSX as of Q2 2026.
- Avior Wealth Management held 8,128 shares of Boston Scientific worth $347K as of Q2 2026.
- Avior Wealth Management sold 1,177 Boston Scientific shares in Q2 2026, an estimated $63.9K.
- Boston Scientific made up 0.01% of Avior Wealth Management's portfolio in Q2 2026, its #612 holding.
- Avior Wealth Management first reported a position in Boston Scientific in Q1 2017 and has held it in 38 quarters since.
- Avior Wealth Management's Boston Scientific position peaked at $975K in Q3 2024.
- 1,470 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.
Based on Avior Wealth Management's 13F filing for Q2 2026, filed 7 Jul 2026.